Proteome of platelets in patients with coronary artery disease

Cristina Banfi1, Maura Brioschi, Giancarlo Marenzi

  • 1Centro Cardiologico Monzino, I.R.C.C.S, Milan, Italy. cristina.banfi@unimi.it

Insights

Platelet protein patterns are altered in coronary artery disease (CAD). Key changes in energy metabolism and cytoskeleton proteins suggest platelet activation in CAD patients.

Area of Science:

  • Cardiovascular Proteomics
  • Platelet Biology
  • Atherosclerosis Research

Background:

  • Platelets play a critical role in the pathophysiology of coronary artery disease (CAD).
  • Understanding platelet protein alterations can provide insights into CAD mechanisms.

Purpose of the Study:

  • To investigate differential protein expression in platelets from patients with stable or acute coronary atherosclerosis (CAD).
  • To identify specific protein patterns associated with CAD and platelet activation.

Main Methods:

  • A proteomic approach was utilized to analyze platelet proteins.
  • Comparison of protein profiles between patients with non-ST elevation acute coronary syndrome, stable angina, and healthy controls.

Main Results:

  • Six differentially expressed proteins were identified, including those in energy metabolism (OGDH, LDH) and cytoskeleton (gamma-actin, coronin 1B, pleckstrin).
  • Increased OGDH and cleaved gamma-actin were observed in CAD patients.
  • LDH was elevated in acute coronary disease, while coronin, proteasome subunit type 8, and pleckstrin isoforms were decreased.

Conclusions:

  • Platelet proteome alterations are associated with stable and acute coronary syndrome.
  • Increased energy metabolism enzymes and altered cytoskeleton proteins indicate platelet activation in CAD.
Abstract

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...